Bristol Myers Squibb reported higher-than-expected first-quarter revenue on Thursday and raised its full-year forecast due to ...

A shortlist of destinations for a potential ferry service linking Swansea and the south-west of England, along with a design ...

Bristol Myers Squibb Co. raised its sales and profit forecasts for the year on better-than-expected sales of older drugs and ...

Reporter Martin Evans travels to Wembley with 40 thousand Bristol City Fans.

Bristol-Myers Squibb raised its 2025 EPS outlook after a Q1 beat, with shares trading far below historical P/E levels. Find ...

93% of music fans in the UK agreed that £1 from every ticket sold for large-scale events should go toward grassroots music ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Gilead Sciences (GILD – Research Report) and ...

Bristol Myers Squibb Co.’s treatment for schizophrenia failed in a study designed to expand its use, denting the company’s ...

New research led by Imperial College London and co-authored by the University of Bristol, has revealed that ariel robotics ...

Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...

Struggling to fit all your training in? Taking advantage of Green Commute Initiative and the Cycle to Work Scheme could help.

Bristol Myers Squibb (BMY) came out with quarterly earnings of $1.80 per share, beating the Zacks Consensus Estimate of $1.51 per share. This compares to loss of $4.40 per share a year ago. These ...